Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4): Upregulation of CTLA-4 has been observed in CD34+ cells from HR-MDS, and levels further increased in the post hypomethylating agents (HMA) failure setting [77]. Here, CD34 is linked to myelodysplastic syndrome.